Carmen J Allegra Selected Research

DNA (Deoxyribonucleic Acid)

12/2020	ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.
7/2014	Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
8/2003	Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carmen J Allegra Research Topics

Disease

20	Neoplasms (Cancer) 11/2022 - 04/2002
17	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 03/2003
16	Colonic Neoplasms (Colon Cancer) 02/2024 - 04/2002
7	Rectal Neoplasms (Rectal Cancer) 12/2020 - 11/2009
7	Carcinoma (Carcinomatosis) 04/2017 - 04/2002
5	Breast Neoplasms (Breast Cancer) 04/2024 - 08/2003
4	Diarrhea 01/2021 - 06/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 10/2021
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2022 - 07/2014
2	Adenocarcinoma 10/2021 - 04/2016
2	Thrombocytopenia (Thrombopenia) 01/2021 - 10/2019
2	Nausea 01/2021 - 10/2019
2	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2010 - 09/2009
2	Microsatellite Instability 03/2007 - 05/2006
1	Neoplasm Metastasis (Metastasis) 12/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Neutropenia 01/2021
1	Stomatitis 01/2021
1	Anemia 01/2021
1	Vomiting 01/2021
1	Leukopenia 01/2021
1	Residual Neoplasm 12/2020
1	Pathologic Complete Response 12/2019
1	Dehydration (Water Stress) 10/2019
1	Fatigue 10/2019
1	Disease Progression 01/2014
1	Obesity 02/2012
1	Hepatocellular Carcinoma (Hepatoma) 09/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2011
1	Hemorrhage 07/2009
1	Thrombotic Thrombocytopenic Purpura 09/2001
1	Hemolytic-Uremic Syndrome 09/2001
1	Pancreatitis 09/2001

Drug/Important Bio-Agent (IBA)

17	Fluorouracil (Carac)FDA LinkGeneric 02/2024 - 01/2003
14	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 07/2009
11	Leucovorin (Folinic Acid)FDA Link 02/2024 - 01/2003
9	Biomarkers (Surrogate Marker)IBA 05/2017 - 08/2003
6	ErbB Receptors (EGF Receptor)IBA 05/2017 - 04/2009
6	Bevacizumab (Avastin)FDA Link 04/2017 - 07/2009
5	neratinibIBA 04/2024 - 10/2019
5	Thymidylate SynthaseIBA 07/2014 - 04/2002
4	Cetuximab (Erbitux)FDA Link 12/2022 - 04/2009
4	Sodium Glutamate (Accent)IBA 11/2021 - 12/2014
4	Trastuzumab (Herceptin)FDA Link 01/2020 - 04/2016
3	Capecitabine (Xeloda)FDA Link 01/2021 - 06/2014
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 08/2003
3	Codon (Codons)IBA 04/2017 - 04/2009
3	Monoclonal AntibodiesIBA 02/2016 - 04/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2022 - 01/2011
2	Panitumumab (Vectibix)FDA Link 01/2021 - 04/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 12/2019
2	human ERBB2 proteinIBA 10/2019 - 04/2016
2	Sorafenib (BAY 43-9006)FDA Link 09/2011 - 01/2011
2	Sunitinib (Sutent)FDA Link 09/2011 - 01/2011
2	Biological FactorsIBA 02/2010 - 09/2009
2	Proteins (Proteins, Gene)FDA Link 05/2006 - 03/2003
1	Ado-Trastuzumab EmtansineIBA 04/2024
1	Immune Checkpoint InhibitorsIBA 11/2022
1	tivozanibIBA 11/2022
1	atezolizumabIBA 11/2022
1	Proteolysis Targeting ChimeraIBA 01/2022
1	DT2216IBA 01/2022
1	snake venom protein C activatorIBA 01/2022
1	sotorasibIBA 01/2022
1	Annexin A5IBA 01/2022
1	src-Family KinasesIBA 10/2021
1	Dasatinib (BMS 354825)FDA Link 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019
1	Hormones (Hormone)IBA 12/2019
1	ElectrolytesIBA 10/2019
1	Transaminases (Aminotransferases)IBA 10/2019
1	pertuzumabIBA 10/2019
1	taxaneIBA 10/2019
1	Calcibiotic Root Canal SealerIBA 05/2017
1	XELOXIBA 03/2016
1	EnzymesIBA 07/2014
1	Angiogenesis InhibitorsIBA 01/2014
1	afliberceptIBA 01/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2014
1	velourIBA 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2011
1	pazopanib FDA Link 01/2011
1	Cytotoxins (Cytolysins)IBA 10/2005
1	Annexin A2 (Annexin II)IBA 08/2003
1	ThymosinIBA 08/2003
1	Biotin (Vitamin H)FDA Link 03/2003
1	AvidinIBA 03/2003
1	thiamine triphosphorate (TTP)IBA 09/2001

Therapy/Procedure

24	Therapeutics 02/2024 - 05/2006
15	Drug Therapy (Chemotherapy) 01/2021 - 01/2003
6	Adjuvant Chemotherapy 01/2021 - 04/2002
4	Neoadjuvant Therapy 01/2018 - 01/2015
2	Immunotherapy 11/2022 - 10/2005
1	Investigational Therapies (Experimental Therapy) 09/2016
1	Radiotherapy 06/2014
1	Chemoradiotherapy 11/2009
1	Adjuvant Chemoradiotherapy 11/2009